Perbedaan Menn Teknologi Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Menn Teknologi Indonesia Tbk. diperdagangkan di Rp53 (kapitalisasi pasar 76 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| MENN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 76 M | 104,4 M |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Menn Teknologi Indonesia Tbk (the Company) was established in the Republic of Indonesia based on the Deed of Establishment No. 2 dated June 23 in Jakarta. The company started its commercial operations in 2015.
Selengkapnya di halaman MENN →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →